Skip to main content
. 2020 Feb 5;12(3):2226–2245. doi: 10.18632/aging.102742

Table 1. The effects of AU on osteoblast differentiation related factors in peripheral blood of Dex-injected mice with osteoporosis.

Groups CTRL AU (15mg/kg) -- E2 (15 μg/kg) Dex(30mg/kg)
AU (mg/kg)
5 15 45
Ca (mmol/L) 1.5±0.1 1.4±0.1 1.3±0.1# 1.6±0.1** 1.5±0.1* 1.5±0.1* 1.5±0.1*
Pi (mmol/L) 2.3±0.2 2.4±0.2 2.1±0.1# 2.4±0.2** 2.4±0.2* 2.4±0.3* 2.2±0.2
E2 (pmol/L) 45.1±2.5 44.4±1.3 40.6±1.2# 44.5±2.5* 44.2±3.3 44.0±6.0 51.3±0.1**
ALP (IU/L) 8.1±1.8 7.7±1.5 5.1±1.0## 7.5±1.3** 6.6±1.0* 7.7±0.8** 6.4±0.3**
Collagen I (ng/mL) 5.2±0.6 5.1±0.6 4.1±0.4## 4.8±0.7* 5.0±0.7* 5.7±0.8*** 5.6±0.7***
OCN (ng/mL) 2.4±0.2 2.6±0.3 2.0±0.2## 2.3±0.2* 2.3±0.1** 2.6±0.3** 2.3±0.2*
OPN (ng/mL) 43.3±3.3 41.2±3.5 36.4±2.3# 42.7±4.0* 41.5±1.5* 42.4±5.7* 44.3±5.4*
BMP-2 (ng/mL) 2.3±0.2 2.2±0.2 1.8±0.2## 2.0±0.2* 1.9±0.3 2.0±0.5 2.4±0.3**
BMPR-2 (ng/mL) 1.2±0.1 1.1±0.1 0.9±0.1## 1.1±0.1* 1.2±0.1** 1.2±0.1** 1.3±0.1**

The data were analyzed using a one-way ANOVA and expressed as means ± S.E.M. (n = 10). # P < 0.05 and ## P < 0.01 versus control mice; * P < 0.05, ** P < 0.01 and ***P < 0.001 versus osteoporosis injured mice.